Rafael Holdings Inc RFL

NYS: RFL | ISIN: US75062E1064   3/05/2024
1,620 USD (0,00%)
(0,00%)   3/05/2024

6 oktober 2021 · Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer · Persbericht

24 september 2021 · Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08 · Persbericht

17 september 2021 · Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 · Persbericht

14 september 2021 · Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer · Persbericht

11 september 2021 · INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, NLOK, MDLA, STMP, GPX; Shareholders are Encouraged to Contact the Firm · Persbericht

4 september 2021 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, RAVN, RFL, STMP; Shareholders are Encouraged to Contact the Firm · Persbericht

26 augustus 2021 · INVESTIGATION: Halper Sadeh LLP Investigates RFL, FIVN, MDLA, CMO, SNR; Shareholders are Encouraged to Contact the Firm · Persbericht

24 augustus 2021 · Rafael Holdings Announces Closing of $104.2 Million Private Placement · Persbericht

20 augustus 2021 · Rafael Holdings Announces $104.2 Million Private Placement · Persbericht

19 augustus 2021 · ALERT: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, HFC, MNR; Shareholders are Encouraged to Contact the Firm · Persbericht

17 augustus 2021 · Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company · Persbericht

11 augustus 2021 · INVESTIGATION: Halper Sadeh LLP Investigates ALTA, TGRF, FFWM, RFL, CLDB; Shareholders are Encouraged to Contact the Firm · Persbericht

4 augustus 2021 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RBNC, GPX, RFL, IKNX; Shareholders are Encouraged to Contact the Firm · Persbericht

28 juli 2021 · SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, FCCY, RBNC, GPX; Shareholders are Encouraged to Contact the Firm · Persbericht

23 juni 2021 · Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference on June 22, 2021 · Persbericht

21 juni 2021 · Rafael Holdings Announces Strategic Merger with Rafael Pharmaceuticals to Form a Focused Late-Stage Clinical Oncology Company · Persbericht

14 juni 2021 · Rafael Holdings Reports Third Quarter Fiscal Year 2021 Results · Persbericht

14 juni 2021 · Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors · Persbericht

28 mei 2021 · Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 · Persbericht

16 april 2021 · Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 · Persbericht

Mijn selecties